logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
T

Takayasu Kurata

Kansai Medical University
H指数:59
被引数:3.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phase II Study of Cisplatin/Gemcitabine Plus Necitumumab for Squamous NSCLC After ICI-Platinum Therapy (WJOG14120L)

WJOG14120L研究：接受ICI-铂类方案治疗后鳞状非小细胞肺癌患者接受顺铂/吉西他滨联合尼昔妥木单抗治疗的II期研究

Cancer Science
IF4.3
2026-10-010
OAAI
Hiroshige Yoshioka; Keita Mori; Nobuhisa Ishikawa; Hiroaki Kanemura; Koichi Azuma; Yukihiro Toi; Hiroshi Handa; Yosuke Tamura; Hiroaki Akamatsu; Haruko Daga; Masafumi Yamaguchi; Teppei Yamaguchi; Yuki Sato; Nobuyuki Yamamoto; Kazuhiko Nakagawa; Takayasu Kurata
Tarlatamab in small cell lung cancer following platinum-based chemotherapy: subgroup analysis of Japanese patients from the DeLLphi-304 study

塔拉他马布在铂类化疗后的小细胞肺癌中的应用：DeLLphi-304研究中日本患者的亚组分析

International Journal of Clinical Oncology
IF2.8
2026-09-190
OAAI
Takayasu Kurata; Shunichi Sugawara; Hiroaki Akamatsu; Kazushige Wakuda; Koichi Azuma; Takayuki Takahama; Hiroshi Kagamu; Hiroshi Yokouchi; Miyako Satouchi; Shuji Murakami; Kadoaki Ohashi; Makoto Nishio; Kazumi Nishino; Hiroki Izumi; Hiroshi Tanaka; Taichi Miyawaki; Shuang Huang; Upen Patil; Jihyun Park; Tatsuya Yoshida
Phase II study of ramucirumab plus erlotinib for treatment-naïve patients with EGFR-mutant non-squamous non-small cell lung cancer and pleural effusion (RELAY-Effusion)

拉姆昔替尼联合厄洛替尼治疗EGFR突变非鳞非小细胞肺癌初治患者伴胸腔积液患者的II期研究（RELAY-Effusion）

Lung Cancer
IF4.4
2026-05-030
OAAI
Hiroyasu Kaneda; Motoko Tachihara; Yukihiro Toi; Shoichi Kuyama; Eiki Ichihara; Yasuhito Fujisaka; Koichi Azuma; Takayasu Kurata; Akihito Kubo; Hisashi Tanaka; Tadaaki Yamada; Toshihide Yokoyama; Takahide Kato; Ken Yamamoto; Nobuyuki Katakami; Ryota Kawai; Hisako Yoshida; Ayumi Shintani; Kenji Sawa; Tomoya Kawaguchi
Clinical trajectory of KRAS G12C-mutated advanced non-small cell lung cancer: a single-center cohort study in Japan

KRAS G12C突变型晚期非小细胞肺癌的临床轨迹：一项日本单中心队列研究

Respiratory Investigation
IF2
2026-05-010
PRE
Okazaki, Yuta; Yoshioka, Hiroshige; Ikoma, Tatsuki; Araki, Keigo; Makihara, Natsuno; Kitagawa, Mai; Nagata, Yutaro; Fujii, Kazuki; Okuno, Yukiko; Kamisako, Keisuke; Nakanishi, Kentaro; Ikeda, Yume; Yoshida, Kiyori; Nakahama, Kahori; Takeyasu, Yuki; Katsushima, Utae; Yamanaka, Yuta; Ikeda, Satoshi; Kurata, Takayasu
Impact of the Lung Immune Prognostic Index in non-small-cell lung cancer patients with PD-L1-low/negative tumors receiving chemoimmunotherapy: a real-world multicenter retrospective study

肺癌免疫预后指数在PD-L1低表达/阴性肿瘤的非小细胞肺癌患者接受化疗免疫治疗中的影响：一项真实世界多中心回顾性研究

ESMO Open
IF8.3
2025-11-200
OAAI
A. Yoshimura; T. Takeda; K. Tanimura; Y. Chihara; H. Kawachi; Y. Yamanaka; N. Tamiya; R. Honda; T. Yamada; K. Uryu; S. Shiotsu; H. Yoshioka; T. Yamada; T. Kurata; K. Takayama
Combined effects of slow movement training with tonic force generation and aerobic exercise prior to cancer therapy in patients with lung cancer (START-lung): a pilot feasibility trial

肺癌患者癌症治疗前的慢速运动训练与持续力量生成及有氧运动的联合效应（START-lung）：一项可行性试点试验

BMC Cancer
IF3.4
2025-10-030
OAAI
Utae Katsushima; Takuya Fukushima; Jiro Nakano; Kazuki Fujii; Yutaro Nagata; Keisuke Kamisako; Yukiko Okuno; Kiyori Yoshida; Tatsuki Ikoma; Yuki Takeyasu; Yuta Yamanaka; Hiroshige Yoshioka; Takayasu Kurata; Eisuke Ochi
Pharmacokinetics and Bioavailability of Pembrolizumab With Berahyaluronidase Alfa for Subcutaneous Administration in Participants With Advanced or Metastatic Solid Tumors: The Phase 1 Study 3475A-C18

帕博利珠单抗联合重组人透明质酸酶α皮下给药的药代动力学与生物利用度研究：晚期或转移性实体瘤患者I期研究3475A-C18

European Journal of Cancer
IF7.1
2025-08-090
PREAI
Graham L. Cohen; Corlia Coetzee; Cathryn A. Walton; Òscar Reig Torras; Byoung Chul Cho; Georgina McAdam; Carlos I. Rojas; Laura Medina Rodríguez; Zsuzsanna Papai; Sze W. Chan; Bernardo L. Rapoport; Christian Caglevic; Patricio Yañez Weber; Toshiaki Takahashi; Takayasu Kurata; Gina Song; Julia W. Cohen; Omobolaji O. Akala; Richard Khanyile
Phase III study of zipalertinib plus fi rst-line (1L) platinum- based chemotherapy in patients (pts) with non-small cell lung cancer (NSCLC) harboring EGFR exon 20 insertion (ex20ins) mutations (REZILIENT3): Safety lead-in results

三代研究：泽帕拉替尼联合一线（1L）铂类为基础的化疗，用于携带EGFR外显子20插入（ex20ins）突变的患者（pts）的非小细胞肺癌（NSCLC）治疗（REZILIENT3）：安全性导入期结果

ANNALS OF ONCOLOGY
IF65.4
2024-12-010
PRE
Kurata, T.; Fujiwara, Y.; Naoki, K.; Viteri, S.; Inoue, T.; Hangai, N.; Wei, L.; Kawabata, R.; Wacheck, V.; Nishio, M.
Comparison of platinum combination chemotherapy plus pembrolizumab versus platinum combination chemotherapy plus nivolumab-ipilimumab for treatment-naive advanced non-small-cell lung cancer in Japan (JCOG2007): an open-label, multicentre, randomised, phase 3 trial
LANCET RESPIRATORY MEDICINE
IF32.8
2024-11-011
PRE
Shiraishi, Yoshimasa; Nomura, Shogo; Sugawara, Shunichi; Horinouchi, Hidehito; Yoneshima, Yasuto; Hayashi, Hidetoshi; Azuma, Koichi; Hara, Satoshi; Niho, Seiji; Morita, Ryo; Yamaguchi, Masafumi; Yokoyama, Toshihide; Yoh, Kiyotaka; Kurata, Takayasu; Okamoto, Hiroaki; Okamoto, Masaki; Kijima, Takashi; Kasahara, Kazuo; Fujiwara, Yutaka; Murakami, Shuji; Kanda, Shintaro; Akamatsu, Hiroaki; Takemoto, Shinnosuke; Kaneda, Hiroyasu; Kozuki, Toshiyuki; Ando, Masahiko; Sekino, Yuta; Fukuda, Haruhiko; Ohe, Yuichiro; Okamoto, Isamu
Multicenter Pharmacokinetic and Pharmacodynamic Study of Pembrolizumab for Non-small-Cell Lung Cancer in Patients Aged 75 Years and Older
CLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
2024-06-173
OAAI
Yagishita, Shigehiro; Yamanaka, Yuta; Kurata, Takayasu; Watanabe, Kageaki; Hosomi, Yukio; Horinouchi, Hidehito; Ohe, Yuichiro; Nakahara, Yoshiro; Naoki, Katsuhiko; Asao, Tetsuhiko; Takahashi, Kazuhisa; Saeki, Sho; Sakagami, Takuro; Nakashima, Kazuhisa; Tsubata, Yukari; Fujita, Yu; Wakui, Hiroshi; Furuta, Megumi; Konishi, Jun Sakakibara; Ohuchi, Mayu; Ando, Yuichi; Mizugaki, Hidenori; Hamada, Akinobu
Impact of the response to platinum-based chemotherapy on the second-line immune checkpoint inhibitor monotherapy in non-small cell lung cancer with PD-L1 expression ≤49%: a multicenter retrospective study
FRONTIERS IN ONCOLOGY
IF3.3
2024-01-260
OAAI
Yoshimura, Akihiro; Takeda, Takayuki; Kataoka, Nobutaka; Tanimura, Keiko; Fukui, Mototaka; Chihara, Yusuke; Takei, Shota; Kawachi, Hayato; Nakanishi, Kentaro; Yamanaka, Yuta; Tamiya, Nobuyo; Honda, Ryoichi; Okura, Naoko; Yamada, Takahiro; Uryu, Kiyoaki; Murai, Junji; Shiotsu, Shinsuke; Yoshioka, Hiroshige; Yamada, Tadaaki; Kurata, Takayasu; Takayama, Koichi
A Retrospective, Multicenter, Observational Study to Evaluate Clinical Outcomes of Lorlatinib After Alectinib in Patients With ALK-Positive NSCLC in Japan
JTO CLINICAL AND RESEARCH REPORTS
IF3.5
2023-05-012
OA
Goto, Yasushi; Kenmotsu, Hirotsugu; Tamiya, Motohiro; Murakami, Shuji; Kurata, Takayasu; Yanagitani, Noriko; Taniguchi, Hirokazu; Kuyama, Shoichi; Shimizu, Junichi; Yokoyama, Toshihide; Shimada, Naoko; Maeda, Tadashi; Tamiya, Akihiro; Uchiyama, Ayumi; Imaizumi, Kazuyoshi; Takahama, Takayuki; Kato, Terufumi; Hayashi, Hidetoshi; Shiraiwa, Naoko; Toyoizumi, Shigeyuki; Kikkawa, Hironori; Thomaidou, Despina; Nishio, Makoto

研究方向

暂未获取到该数据
K
Kazuhiko Nakagawa
H 指数:103论文数:1,451被引数:6.1万
H
Hiroshige Yoshioka
H 指数:49论文数:356被引数:1.6万
I
Isamu Okamoto
H 指数:75论文数:756被引数:3.3万
Y
Yuichiro Ohe
H 指数:76论文数:958被引数:4.1万
Y
Yasuhito Fujisaka
H 指数:19论文数:105被引数:5,105
N
Nobuyuki Yamamoto
H 指数:73论文数:1,055被引数:2.9万
Y
Yuta Yamanaka
H 指数:9论文数:79被引数:226
H
Hiroyasu Kaneda
H 指数:35论文数:261被引数:5,943
J
Jhanelle E. Gray
H 指数:54论文数:728被引数:3.4万
H
Hideo Saka
H 指数:48论文数:378被引数:1.3万